Search

everythinglearnresearchcommunity

for

Search:↓

The combined stem cell secretome in the skin care product effectively reduces inflammation and promotes tissue regeneration.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

New treatments are needed for non-scarring alopecia due to current limitations.

Alkaloids help fight influenza in animals but need more research for human use.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Frankincense may help treat COVID-19, but more research is needed.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Hair dye ingredient PPD causes cell death and aging in human hair cells by altering microRNA levels.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Ischemia-modified albumin can help diagnose ischemic conditions early, but better detection methods are needed.

sPLA2-X is crucial for normal hair growth and follicle health.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.

Hair cortisol levels peak in the third trimester and decline postpartum.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Mitochondrial stress can lead to atopic dermatitis.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Hair follicle stem cells can help treat ulcerative colitis in mice by releasing beneficial exosomes.

LONRF1 is important for oxidative damage response and tissue remodeling during wound healing.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Alopecia Areata might be linked to Crohn's disease.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.